Smart algorithm could transform ICU diabetes care

NCT ID NCT07385391

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study aims to create a new algorithm that uses continuous glucose monitoring to assess insulin resistance in real time for critically ill patients. Current methods are often invasive or impractical in the ICU. Researchers will analyze data from 179 patients to see if this new metric relates to patient outcomes like organ function and survival.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to a non-invasive, real-time tool to help doctors manage blood sugar and insulin needs in critically ill patients.

What could go wrong

This is an observational study, not a treatment trial. The algorithm may not prove accurate or useful in all ICU settings, and further validation will be needed.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INSULIN RESISTANCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Critical Illness Insulin Resistance metabolic disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Nanjing Drum Tower Hospital

    Nanjing, Jiangsu, 210000, China